{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T01:08:11Z","timestamp":1711588091900},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,27]]},"DOI":"10.7759\/cureus.57044","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:01:21Z","timestamp":1711551681000},"source":"Crossref","is-referenced-by-count":0,"title":["Double Seronegative Neuromyelitis Optica Spectrum Disorder with Longitudinally Extensive Transverse Myelitis and Optic Neuritis: A Challenging Case Report"],"prefix":"10.7759","author":[{"given":"Goh","family":"Chon Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tajunisah","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowri","family":"Supramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda S","year":"2019","unstructured":"Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A. Neuromyelitis optica spectrum disorders. Clin Med (Lond). 2019, 19:169-76. 10.7861\/clinmedicine.19-2-169","journal-title":"Clin Med (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon VA","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005, 202:473-7. 10.1084\/jem.20050304","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor JY","year":"2020","unstructured":"Hor JY, Asgari N, Nakashima I, et al.. Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide. Front Neurol. 2020, 11:501. 10.3389\/fneur.2020.00501","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015, 85:177-89. 10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318296ea08","article-title":"Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders","volume":"80","author":"Sato DK","year":"2013","unstructured":"Sato DK, Nakashima I, Takahashi T, et al.. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology. 2013, 80:2210-6. 10.1212\/WNL.0b013e318296ea08","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231199819","article-title":"Double-negative neuromyelitis optica spectrum disorder","volume":"29","author":"Wu Y","year":"2023","unstructured":"Wu Y, Geraldes R, Jury\u0144czyk M, Palace J. Double-negative neuromyelitis optica spectrum disorder. Mult Scler. 2023, 29:1353-62. 10.1177\/13524585231199819","journal-title":"Mult Scler"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato DK","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, et al.. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014, 82:474-81. 10.1212\/WNL.0000000000000101","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/11795735211057315","article-title":"Visual evoked potentials in neuromyelitis optica spectrum disorders","volume":"13","author":"Hernandez Fustes OJ","year":"2021","unstructured":"Hernandez Fustes OJ, Kay CS, Lorenzoni PJ, Ducci RD, Werneck LC, Scola RH. Visual evoked potentials in neuromyelitis optica spectrum disorders. J Cent Nerv Syst Dis. 2021, 13:1-5. 10.1177\/11795735211057315","journal-title":"J Cent Nerv Syst Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181af78b8","article-title":"Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies","volume":"73","author":"Ratchford JN","year":"2009","unstructured":"Ratchford JN, Quigg ME, Conger A, et al.. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009, 73:302-8. 10.1212\/WNL.0b013e3181af78b8","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/180956-double-seronegative-neuromyelitis-optica-spectrum-disorder-with-longitudinally-extensive-transverse-myelitis-and-optic-neuritis-a-challenging-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:01:31Z","timestamp":1711551691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/180956-double-seronegative-neuromyelitis-optica-spectrum-disorder-with-longitudinally-extensive-transverse-myelitis-and-optic-neuritis-a-challenging-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.57044","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,27]]}}}